Treasurer of the State of North Carolina’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.88M | Buy |
88,809
+2,407
| +3% | +$132K | 0.02% | 657 |
|
|
2025
Q1 | $6.11M | Sell |
86,402
-9,462
| -10% | -$669K | 0.02% | 535 |
|
|
2024
Q4 | $6.3M | Buy |
95,864
+1,900
| +2% | +$125K | 0.02% | 535 |
|
|
2024
Q3 | $6.61M | Sell |
93,964
-6,440
| -6% | -$453K | 0.03% | 532 |
|
|
2024
Q2 | $8.27M | Sell |
100,404
-4,319
| -4% | -$356K | 0.04% | 427 |
|
|
2024
Q1 | $9.15M | Buy |
104,723
+640
| +0.6% | +$55.9K | 0.04% | 412 |
|
|
2023
Q4 | $10M | Buy |
104,083
+6,050
| +6% | +$583K | 0.05% | 362 |
|
|
2023
Q3 | $8.67M | Sell |
98,033
-3,960
| -4% | -$350K | 0.05% | 373 |
|
|
2023
Q2 | $8.84M | Buy |
101,993
+3,120
| +3% | +$270K | 0.05% | 377 |
|
|
2023
Q1 | $9.61M | Buy |
98,873
+1,050
| +1% | +$102K | 0.05% | 348 |
|
|
2022
Q4 | $10.1M | Buy |
97,823
+2,560
| +3% | +$265K | 0.06% | 321 |
|
|
2022
Q3 | $8.08M | Sell |
95,263
-650
| -0.7% | -$55.1K | 0.05% | 354 |
|
|
2022
Q2 | $7.95M | Buy |
95,913
+14,047
| +17% | +$1.16M | 0.05% | 367 |
|
|
2022
Q1 | $6.31M | Buy |
81,866
+1,093
| +1% | +$84.3K | 0.03% | 447 |
|
|
2021
Q4 | $7.14M | Buy |
80,773
+2,876
| +4% | +$254K | 0.04% | 427 |
|
|
2021
Q3 | $6.02M | Buy |
77,897
+1,909
| +3% | +$148K | 0.03% | 461 |
|
|
2021
Q2 | $6.34M | Sell |
75,988
-4,610
| -6% | -$385K | 0.04% | 446 |
|
|
2021
Q1 | $6.09M | Sell |
80,598
-260
| -0.3% | -$19.6K | 0.04% | 437 |
|
|
2020
Q4 | $7.09M | Buy |
80,858
+2,550
| +3% | +$224K | 0.05% | 359 |
|
|
2020
Q3 | $5.96M | Buy |
78,308
+9,190
| +13% | +$699K | 0.05% | 360 |
|
|
2020
Q2 | $8.53M | Sell |
69,118
-7,495
| -10% | -$924K | 0.07% | 261 |
|
|
2020
Q1 | $6.47M | Buy |
76,613
+30,710
| +67% | +$2.6M | 0.06% | 295 |
|
|
2019
Q4 | $3.88M | Buy |
45,903
+890
| +2% | +$75.2K | 0.03% | 381 |
|
|
2019
Q3 | $3.03M | Sell |
45,013
-26,780
| -37% | -$1.81M | 0.03% | 429 |
|
|
2019
Q2 | $6.15M | Buy |
71,793
+1,440
| +2% | +$123K | 0.04% | 401 |
|
|
2019
Q1 | $6.25M | Buy |
70,353
+645
| +0.9% | +$57.3K | 0.04% | 381 |
|
|
2018
Q4 | $5.94M | Buy |
69,708
+2
| +0% | +$170 | 0.04% | 352 |
|
|
2018
Q3 | $6.76M | Buy |
69,706
+29,876
| +75% | +$2.9M | 0.04% | 362 |
|
|
2018
Q2 | $3.75M | Buy |
39,830
+23,595
| +145% | +$2.22M | 0.04% | 364 |
|
|
2018
Q1 | $1.32M | Buy |
+16,235
| New | +$1.32M | 0.03% | 479 |
|